XB-ART-18549
Nature
1996 Feb 08;3796565:545-8. doi: 10.1038/379545a0.
Show Gene links
Show Anatomy links
Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels.
???displayArticle.abstract???
Sulphonylureas are a class of drugs widely used to treat non-insulin-dependent diabetes mellitus. These drugs act by binding to a sulphonylurea receptor (SUR) in the pancreatic beta-cell membrane which inhibits an ATP-sensitive potassium (K-ATP) channel and thereby stimulates insulin secretion. There has been much debate as to whether SUR and the K-ATP channel are the same or separate proteins, whether SUR confers ATP-sensitivity on an ATP-insensitive pore-forming subunit, and whether sulphonylureas can also modulate other types of K-channel. We show here that SUR itself does not possess intrinsic channel activity but that it endows sulphonylurea sensitivity on several types of inwardly-rectifying K-channels. It does not necessarily confer ATP-sensitivity on these channels.
???displayArticle.pubmedLink??? 8596634
???displayArticle.link??? Nature
???displayArticle.grants???
Species referenced: Xenopus
Genes referenced: abcc8 ins